secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001193125-25-154062
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics prices $100M public offering at $23.50 per share
--------------------------------------------------------------------

- Nektar prices 4,255,320 shares at $23.50/share for gross proceeds of $100M.
- Net proceeds estimated at $93.7M ($107.8M if underwriters' option exercised in full).
- Offering expected to close July 2, 2025; Jefferies and Piper Sandler are joint bookrunners.
- Proceeds to fund R&D, clinical development, manufacturing, and other general corporate purposes.
- Underwriters have a 30-day option to purchase up to an additional 638,298 shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/0001193125-25-154062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/d943939d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-154062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer